The primary purpose of this analysis was to develop a deeper understanding of the overall strength of the contract service providers involved in this field. It allows companies to compare their existing capabilities within their respective peer groups and identify ways to gain a competitive edge in the industry. In addition, this analysis can be used by the companies to ascertain improvement areas by identifying the gaps between their existing capabilities and the best available practices in the industry.
To request a sample copy / brochure of this report, please visit this
https://www.rootsanalysis.com/reports/biospecimen-contract-research-services-market/request-sample.html
In this analysis, we have compared around 40 companies providing services related to biospecimens across multiple parameters. We have analyzed all the companies and plotted a four-dimensional bubble analysis with supplier power on the abscissa, service strength on the ordinate, manufacturing strength as the size of the bubble and company size as the color of bubble. The primary purpose of this analysis is to compare the popularity and activity of different biospecimen related service providers on a relative basis. At no point, should the discussion in this analysis be construed as a firm recommendation that one drug product service provider is better than the others. It is important to mention that this analysis has been done based on the information collated from various publicly available sources and the information disclosed by the company.
The company offers biobanking services for biospecimen at its Michigan, US facility. Further, the company claims to offer close to 20 different types of biospecimens, including saliva, cerebrospinal fluid, whole blood, plasma, serum, blood cells and others. In addition, the company offers different analytical services, including tumor tissue analysis, cell-based assays, target validation services, tissue microarrays and histological services.
Further, it is worth mentioning that, Company 5 has maximum score in terms of service strength. The company was established in 2009 and claims to offer around 15 different types of biospecimens. The company offers services related to tissue microarrays and offer both healthy and diseased samples. It is worth mentioning that the company has received accreditations from IRB, IEC and ISBER, HIPAA and GCP.
One of the key objectives of the report was to estimate the current market size and the growth opportunities in the biospecimen contract research market, over the next decade. Based on different parameters, such as overall human biological sample market, share of commercial biobanks and share of biospecimen contract research service providers, we have provided informed estimates on the evolution of the market for the period 2021-2030.
For additional details, please visit
https://www.rootsanalysis.com/reports/biospecimen-contract-research-services-market.html
You may also be interested in the following titles:
- Regulatory T-Cell Therapies (Tregs) Market, 2021–2035
- CD47 Targeting Therapeutics Market, 2021-2035
- Light Activated Therapies Market, 2021-2030
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
Ben.johnson@rootsanalysis.com
Facebook – https://www.facebook.com/RootsAnalysis
LinkedIn – https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter – https://twitter.com/RootsAnalysis
Medium – https://medium.com/@RootsAnalysis
Pinterest – https://in.pinterest.com/RootsanalysisPin/_saved/
Quora – https://rootsanalysisinsights.quora.com/
